Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

NCT00186420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Taxotere

Sponsor

Stanford University

Collaborators

[object Object]